Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Convatec Group Plc, headquartered in Great Britain, is a leading player in the medical, precision, and optical instruments industry. Founded in 1978, the company has established itself as a pioneer in advanced wound care, ostomy care, continence and critical care, and infusion devices. With a strong presence in Europe, North America, and Asia-Pacific, Convatec is committed to enhancing patient outcomes through innovative healthcare solutions.
The company’s core products, including advanced wound dressings and ostomy appliances, are distinguished by their quality and effectiveness, addressing the unique needs of patients and healthcare professionals alike. Convatec's dedication to research and development has positioned it as a trusted name in the industry, achieving significant milestones such as the launch of groundbreaking products that improve patient quality of life. With a robust market position, Convatec continues to drive advancements in medical technology, making a meaningful impact in the healthcare sector.
+43 vs industry average
Convatec’s score of 75 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has typical carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
Convatec, a UK-based company in the Medical, precision and optical instruments, watches and clocks industry, reported total Scope 1, 2, and 3 emissions of 295,296,000 kg CO2e for 2025. This includes approximately 12,780,000 kg CO2e from Scope 1 emissions, 85,000 kg CO2e from market-based Scope 2 emissions, and 282,431,000 kg CO2e from Scope 3 emissions.
Looking back, their total emissions were approximately 247,413,000 kg CO2e in 2024, 262,913,000 kg CO2e in 2023, 282,242,000 kg CO2e in 2022, and 302,837,000 kg CO2e in 2021.
Convatec has set ambitious climate commitments. Their strategic ambition is to achieve net zero by 2045, covering all scopes of emissions. In line with Science Based Targets (SBTs), they aim to reduce combined Scope 1 and 2 (market-based) emissions by 70% by 2030, against a 2021 baseline. Furthermore, they are committed to reducing Scope 3 upstream and downstream emissions by 52% per sold product by 2030, also against a 2021 baseline. These Scope 3 targets specifically cover emissions from purchased goods and services, upstream transportation and distribution, and waste generated in operations. Convatec's near-term targets have been validated by the Science Based Targets initiative (SBTi) as consistent with reductions required to keep warming to 1.5°C.
Access structured emission data, company specific factors and auditable source documents
2030
70% reduction in Scope 2
Convatec commits to reduce absolute scope 1 and 2 GHG emissions 70% by 2030 from a 2021 base year. Convatec also commits to reduce scope 3 G…
2030
70% reduction in Scope 1
Convatec commits to reduce absolute scope 1 and 2 GHG emissions 70% by 2030 from a 2021 base year. Convatec also commits to reduce scope 3 G…
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


Common questions about Convatec’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more